@sallysansom.bsky.social
#HEOR & #PCOR Doctoral Researcher @herc-oxford.bsky.social • Research Fellow @cpmoxford.bsky.social • Clarendon Scholar • Coordinator @ihea-econ-omics.bsky.social • #healtheconomics • #outcomesresearch • #genomesequencing • #genetherapies • #raredisease
UPCOMING WEBINAR
From Crib to Clinic: The Economic and Ethical Trade-offs of Genomic Sequencing in Newborn Screening and Diagnosis
Dr @hadleyssmith.bsky.social
Tues 21 Oct 10:30 h UK BST onsite/online
Free event registration app.onlinesurveys.jisc.ac.uk/s/oxford/her...
@oxpop.bsky.social
(1/3) 🎙️ New episode from the Centre for Personalised Medicine podcast!
We explore the “#HealthEconomics of #PersonalisedMedicine” with host @rachel-horton.bsky.social and expert guests
🎧 Listen:
Apple: podcasts.apple.com/gb/podcast/s...
Spotify: open.spotify.com/episode/1Q9Y...
(1/4) NEXT WEEK: Applying #MendelianRandomization in #HealthEconomics - Bridging #Genomics & #CostEffectiveness
🗓️ Tues 16 Sept
⏰ 8-9 AM UTC / 9-10 AM BST / 6-7 PM AEST
📍 Online, download the calendar invite here: healtheconomics.org/event/applyi...
(1/4) INVITATION: Applying #MendelianRandomization in #HealthEconomics - Bridging #Genomics & #CostEffectiveness
🗓️ Tues 16 Sept
⏰8-9 AM UTC / 9-10 AM BST / 6-7 PM AEST
📍Online, download the calendar invite here: healtheconomics.org/event/applyi...
🔔 FINAL EXTENSION: The #IHEA Econ-Omics SIG global survey on integrating #healtheconomics into #genomicmedicine is still open and the deadline has been extended to Friday 15 August!
We’d love your input! No economics background needed.
🕒 ~15 mins
🔗 q.surveys.unimelb.edu.au/jfe/form/SV_...
🔔 REMINDER: The #IHEA Econ-Omics SIG global survey on integrating #healtheconomics into #genomicmedicine is still open and the deadline has been extended to Friday 25 July!
We’d love your input! No economics background needed.
🕒 ~15 mins
🔗 q.surveys.unimelb.edu.au/jfe/form/SV_...
The recording from this event is now available on YouTube! #earlycareerresearchers #ECRs #healtheconomics #genomics #precisionmedicine www.youtube.com/watch?v=2HeE...
16.07.2025 17:06 — 👍 2 🔁 1 💬 0 📌 0(1/5) 🧬 How can we better integrate #healtheconomics into genomic medicine?
The #IHEA Econ-Omics SIG has launched a global survey to explore this question, and we want to hear from you!
🕒 ~15 mins | 🔗 Take part: q.surveys.unimelb.edu.au/jfe/form/SV_...
#genomics #precisionmedicine
(1/6) Calling all Early Career Researchers & Health Economists interested in Genomics & Precision Medicine!
The #IHEA Econ-Omics SIG invites you to our ECR Journal Club webinar:
🗓️ Tuesday, 15 July
⏰ 8-10am UTC | 9-11am BST | 6-8pm AEST
🔗 Register: healtheconomics.org/event/early-...
(5/5) Huge thanks to @hadleyssmith.bsky.social and to everyone I met for making my visit so productive and memorable. I’m looking forward to carrying this momentum into the next phase of my research!
23.06.2025 09:57 — 👍 1 🔁 0 💬 0 📌 0(4/5) Beyond the academic side of things, I was sure to make the most of my first trip to Boston including exploring the city and catching a Red Sox game at Fenway Park!
23.06.2025 09:57 — 👍 0 🔁 0 💬 1 📌 0(3/5) I was also thrilled to have an opportunity to present my research to the Precision Medicine Translational Research Center (PROMoTeR), and to meet with leading researchers at Harvard, Tufts, the Broad Institute, and Boston Children’s Hospital, whose work has directly informed my own.
23.06.2025 09:56 — 👍 0 🔁 0 💬 1 📌 0(2/5) @hadleyssmith.bsky.social and colleagues' model of perceived utility of genomic sequencing has been foundational to my research on measuring patient- and caregiver-reported outcomes from #genomesequencing for #raredisease diagnosis within a #healtheconomics context.
23.06.2025 09:56 — 👍 0 🔁 0 💬 1 📌 0
(1/5) I recently returned from a 1-month research visit at the @deptpopmed.bsky.social within @harvardmed.bsky.social, generously hosted by @hadleyssmith.bsky.social and her team. This visit was an exciting opportunity to build on our collaboration and to advance core components of my PhD.
23.06.2025 09:56 — 👍 5 🔁 2 💬 1 📌 1(2/2) It was a great experience to share my research and to meet others who are passionate about tackling some really complex questions in #HEOR. Thanks to everyone who stopped by my poster for a chat! You can also view my poster here: bit.ly/Sansom_PCR42...
23.05.2025 16:25 — 👍 2 🔁 0 💬 0 📌 0
(1/2) I spent last week in Montreal at #ISPORAnnual where I presented my poster titled: “Measuring Patient- and Carer-Reported Outcomes Following #GenomeSequencing for #RareDiseaseDiagnosis: A Psychometric Assessment of Outcome Measurement Instruments”. #ISPOR @herc-oxford.bsky.social
23.05.2025 16:24 — 👍 4 🔁 2 💬 1 📌 0I’ll be standing by my poster at #ISPORAnnual from 12:30-1:30pm today and would love to chat all things #genomics, #raredisease, #patientoutcomes, #caregiveroutcomes and #psychometrics!
14.05.2025 14:22 — 👍 1 🔁 0 💬 0 📌 0
We have two vacancies for Junior Research Fellows to join the CPM team next academic year. Please repost and send to anyone who might be interested. shorturl.at/DOV5s
30.04.2025 10:00 — 👍 4 🔁 2 💬 0 📌 2
Excited to share that I’ll be presenting my PhD work at ISPOR in Montreal! My poster on patient- and carer-reported outcomes from #genomesequencing is in Poster Session 1 from 10:30am-1:30pm 14 May (discussion period: 12:30-1:30pm). Hope to see you there! #ISPORAnnual #HEOR #RareDiseases #Genomics
28.04.2025 10:16 — 👍 11 🔁 2 💬 0 📌 2It's not too late to sign up to attend this fascinating event, a week today:
22.04.2025 14:28 — 👍 2 🔁 2 💬 0 📌 0
We are delighted to be hosting an evening of talks about the discovery of ReNU syndrome, at 17:30 on Tuesday 29th April at St Anne's College. Further information, and registration details can be found here: cpm.ox.ac.uk/event/the-di...
We hope to see you there!
(1/4) Attention Early Career Researchers (ECRs)! We are still collecting expressions of interest for our ECR ‘Preprint Club’ series for 2025. #IHEA #healtheconomics #genomics #precisionmedicine
18.03.2025 09:26 — 👍 4 🔁 4 💬 1 📌 0
Had a great day on Tuesday reflecting on evolving #NewbornScreening and the opportunities and challenges it brings. Also on a #Risk&Prevention theme, our @cpmoxford.bsky.social podcast episode with Dr Malte Gerhold from @healthfoundation.bsky.social is now online!: podcasts.ox.ac.uk/series-3-epi...
28.02.2025 09:47 — 👍 4 🔁 6 💬 1 📌 0Reflecting on the recent @cpmoxford.bsky.social 'Making Progress with #NewbornScreening' conference: An insightful day exploring the scientific, health economics, policy, and ethical dimensions of expanding newborn screening for rare diseases! #PersonalisedMedicine @cambup-lifesci.bsky.social
27.02.2025 09:10 — 👍 3 🔁 3 💬 0 📌 0
Thrilled to have had an opportunity to share some insights from my PhD at the #EuroQol UK & Ireland meeting! Had a great time discussing how best to measure patient and carer impacts from #genomesequencing for #raredisease diagnosis in economic evaluations! #healtheconomics #healthoutcomes #PROMs
24.02.2025 21:19 — 👍 7 🔁 2 💬 0 📌 0
The recording from Professor Katherine Payne’s talk on generating economic evidence to understand the potential impact of pharmacogenetic testing is now available! #healtheconomics #pharmacogenetics www.youtube.com/watch?v=tze_...
12.02.2025 09:09 — 👍 4 🔁 3 💬 0 📌 1
There's just 1 week to go until our Annual Lecture from @philipcball.bsky.social at the Sheldonian Theatre, 'How life works: Dealing with biology’s changing narrative'.
All welcome! You can register here: cpm.ox.ac.uk/event/cpm-an...
NEXT WEEK: Join Professor Katherine Payne’s talk on generating economic evidence to understand the potential impact of pharmacogenetic testing #IHEA #healtheconomics #pharmacogenetics healtheconomics.org/event/econ-o...
03.02.2025 14:48 — 👍 3 🔁 3 💬 0 📌 1
#january Day 29
Today we’re very excited to share the first episode of our new podcast series! It starts with the CPM team talking about what we mean by #PersonalisedMedicine – listen here: https://buff.ly/3WBqWcA
Thank you @researchpodcasts.bsky.social for all your support creating this
#january Day 27
#Genome sequencing can improve the chance of finding a diagnosis for people with rare disease, but what challenges do health economists face when measuring the impact of this technology? Our JRF @sallysansom.bsky.social from HERC Oxford explores this:
